Compositions for achieving a therapeutic effect in an anatomical structure and methods of using the same
Compositions and methods of using the compositions to achieve a therapeutic effect are provided.
1. A particle to form an embolus within a region of an anatomical lumen, the particle including a particle material and a hygroscopic substance that is different from the particle material, the combination of the particle material and the hygroscopic substance selected such that the particle disintegrates into fragments thereby forming multiple emboli within the anatomical lumen for a transitory period, wherein the hygroscopic substance comprises a disintegrant selected from the group consisting of croscarmellose, povidone, galactose, lactose, and mannose; and wherein the particle material comprises a biodegradable inorganic substance.
2. The particle of claim 1 , further comprising a therapeutic substance.
3. The particle of claim 1 , wherein the biodegradable inorganic substance is selected from the group consisting of hydroxyapatite, dahlite, brushite, calcium sulphate, octacalcium phosphate, amorphous calcium phosphate and beta-tricalcium phosphate.
4. The particle of claim 1 , further including a polymeric material.
5. A particle to form an embolus within a region of an anatomical lumen, comprising a particle material and a disintegrant, wherein the disintegrant disintegrates the particle that forms the embolus within the region for a transitory period and is selected from the group consisting of croscarmellose, povidone, galactose, lactose, and mannose; and wherein the particle material comprises a biodegradable inorganic substance.
6. The particle of claim 5 , further comprising a therapeutic substance.
7. The particle of claim 6 , wherein the therapeutic substance is selected from the group consisting of antineoplastic, antiplatelet, anticoagulant, fibrinolytic, antimitotic, thrombin inhibitor, antiinflammatory, antiproliferative, antioxidant, antiangiogenic, angiogenic, arteriogenic and antiallergic substances, and mixtures thereof.
8. The particle of claim 6 , wherein the particle is configured to release the therapeutic substance.
9. The particle of claim 5 , further comprising a polymeric material.
10. The particle of claim 5 , wherein the transitory period is less than seven days.
11. The particle of claim 5 , wherein the transitory period is less than the duration which results in cell damage or cell death in the region of the anatomical lumen being treated by the particle.
12. The particle of claim 5 , wherein the disintegrant allows a diameter of the particle to be reduced.
13. The particle of claim 5 , wherein the disintegrant allows the particle to disintegrate into fragments.
14. The particle of claim 5 , wherein the disintegrant is dispersed within the particle.
15. The particle of claim 5 , wherein the disintegrant is concentrated at one or more areas of the particle.